US5122127A
(en)
*
|
1985-05-01 |
1992-06-16 |
University Of Utah |
Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
|
US4983395A
(en)
*
|
1987-11-12 |
1991-01-08 |
Theratech Inc. |
Device for administering an active agent to the skin or mucosa
|
DE3809978A1
(de)
*
|
1988-03-24 |
1989-10-05 |
Lohmann Gmbh & Co Kg |
Reservoir fuer gesteuerte wirkstoffabgabe, dieses enthaltende vorrichtung, sowie verfahren zu deren herstellung und verwendung der vorrichtung
|
US4900552A
(en)
*
|
1988-03-30 |
1990-02-13 |
Watson Laboratories, Inc. |
Mucoadhesive buccal dosage forms
|
EP0432945A1
(de)
*
|
1989-12-12 |
1991-06-19 |
Warner-Lambert Company |
Transdermales Abgabesystem zur Behandlung der Kokain- und Heroinsucht
|
US6132849A
(en)
*
|
1990-10-30 |
2000-10-17 |
Minnesota Mining And Manufacturing Company |
Receptive media for permanent imaging and methods of preparing and using same
|
US5443727A
(en)
*
|
1990-10-30 |
1995-08-22 |
Minnesota Mining And Manufacturing Company |
Articles having a polymeric shell and method for preparing same
|
US5164190A
(en)
*
|
1990-12-11 |
1992-11-17 |
Theratech, Inc. |
Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
|
US5273755A
(en)
*
|
1991-08-23 |
1993-12-28 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
|
US5273756A
(en)
*
|
1991-08-23 |
1993-12-28 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
|
US5276079A
(en)
*
|
1991-11-15 |
1994-01-04 |
Minnesota Mining And Manufacturing Company |
Pressure-sensitive poly(n-vinyl lactam) adhesive composition and method for producing and using same
|
MX9302812A
(es)
*
|
1992-05-13 |
1993-11-01 |
Alza Corp |
Administracion transdermica de oxibutinina.
|
US5900250A
(en)
*
|
1992-05-13 |
1999-05-04 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutnin
|
CA2097163C
(en)
*
|
1992-06-01 |
2002-07-30 |
Marianna Foldvari |
Topical patch for liposomal drug delivery system
|
JPH0679002A
(ja)
*
|
1993-12-14 |
1994-03-22 |
Hisamitsu Pharmaceut Co Inc |
経皮投与用パッチシステム
|
US5346701A
(en)
*
|
1993-02-22 |
1994-09-13 |
Theratech, Inc. |
Transmucosal delivery of macromolecular drugs
|
IL113034A
(en)
*
|
1994-04-05 |
2000-02-17 |
Astra Ab |
Topical dressing
|
US5639469A
(en)
*
|
1994-06-15 |
1997-06-17 |
Minnesota Mining And Manufacturing Company |
Transmucosal delivery system
|
CA2208132A1
(en)
*
|
1994-12-21 |
1996-06-27 |
Theratech, Inc. |
Transdermal delivery system with adhesive overlay and peel seal disc
|
DE19517145C2
(de)
*
|
1995-05-10 |
2000-02-24 |
Hexal Pharmaforschung Gmbh |
Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
|
US5891461A
(en)
*
|
1995-09-14 |
1999-04-06 |
Cygnus, Inc. |
Transdermal administration of olanzapine
|
US5902603A
(en)
*
|
1995-09-14 |
1999-05-11 |
Cygnus, Inc. |
Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
|
US5730721A
(en)
*
|
1996-01-25 |
1998-03-24 |
Vesture Corporation |
Medical applicator and method
|
BR9713492A
(pt)
*
|
1996-10-30 |
2000-02-29 |
Theratech Inc |
ésteres de ácido graxo de ácido glicólico e seus sais como realçadores de permeação
|
US6096943A
(en)
*
|
1998-01-09 |
2000-08-01 |
Maiwald; Diane C |
Skin wound protector
|
EP1039880A1
(de)
*
|
1998-10-23 |
2000-10-04 |
Idea Innovative Dermale Applikationen GmbH |
Verfahren zum entwickeln,prüfen,und verwenden von makromolekülenassoziaten und komplexenaggregaten für verbesserte nutzlast und steuerbare kombinations/abtrennungsgeschwindigkeit
|
EP1031347B1
(de)
|
1999-01-27 |
2002-04-17 |
Idea Ag |
Transnasaler Transport bzw. Impfung mit hochadaptierbaren Trägern
|
PT1031346E
(pt)
|
1999-01-27 |
2002-09-30 |
Idea Ag |
Vacinacao nao invasiva atraves da pele
|
US6277401B1
(en)
*
|
1999-05-07 |
2001-08-21 |
U.S. Dermatologics, Inc. |
Drug delivery device
|
DE19923427A1
(de)
*
|
1999-05-21 |
2000-11-23 |
Lohmann Therapie Syst Lts |
Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
|
US6232366B1
(en)
|
1999-06-09 |
2001-05-15 |
3M Innovative Properties Company |
Pressure sensitive conductive adhesive having hot-melt properties and biomedical electrodes using same
|
CA2376797C
(en)
|
1999-06-11 |
2011-03-22 |
Watson Pharmaceuticals, Inc. |
Administration of non oral androgenic steroids to women
|
MXPA02000053A
(es)
*
|
1999-07-05 |
2003-07-21 |
Idea Ag |
Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
|
WO2001032115A1
(en)
*
|
1999-11-04 |
2001-05-10 |
Xel Herbaceuticals |
Transdermal administration of huperzine
|
US6896898B1
(en)
|
1999-11-19 |
2005-05-24 |
Xel Herbaceuticals, Inc. |
Transdermal delivery system for alkaloids of aconitum species
|
US20050042271A1
(en)
*
|
1999-11-19 |
2005-02-24 |
Xel Herbaceuticals, Inc . |
Transdermal delivery system for alkaloids of aconitum species
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
DE10040592A1
(de)
*
|
2000-08-15 |
2002-03-07 |
Aventis Res & Tech Gmbh & Co |
Formulierung zur verbesserten Aufnahme von Wirkstoffen und deren Verwendung
|
US6709716B2
(en)
|
2001-04-27 |
2004-03-23 |
3M Innovative Properties Company |
Microemulsion compositions and methods of making and using same
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
ES2587187T3
(es)
|
2001-05-01 |
2016-10-21 |
A. V. Topchiev Institute Of Petrochemical Synthesis |
Composición bioadhesiva absorbente de agua bifásica
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
EP1390085B1
(de)
*
|
2001-05-01 |
2009-08-05 |
A.V. Topchiev Institute of Petrochemical Synthesis |
Hydrogel-zusammensetzungen
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
DE10141651B4
(de)
*
|
2001-08-24 |
2007-02-15 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
|
DE10160110A1
(de)
*
|
2001-12-07 |
2003-06-26 |
Norbert Hoenzelaer |
Vorrichtung und Pflaster zur kontrollierten Freisetzung von Vanillin
|
US7921999B1
(en)
|
2001-12-20 |
2011-04-12 |
Watson Laboratories, Inc. |
Peelable pouch for transdermal patch and method for packaging
|
US20050191340A1
(en)
*
|
2002-08-09 |
2005-09-01 |
Gruenenthal Gmbh |
Opioid-receptor antagonists in transdermal systems having buprenorphine
|
DE60325486D1
(de)
|
2002-08-30 |
2009-02-05 |
Alza Corp |
Prägbare und beschreibbare verbundrückschicht
|
WO2004028515A1
(en)
*
|
2002-09-26 |
2004-04-08 |
Young-Kweon Choi |
Matrix type patch for transdermal administration of vitamin d analog and the use thereof
|
US7473432B2
(en)
*
|
2002-10-11 |
2009-01-06 |
Idea Ag |
NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
|
CA2453013C
(en)
*
|
2002-12-13 |
2011-02-15 |
Gary W. Cleary |
Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
|
US9278155B2
(en)
|
2003-06-05 |
2016-03-08 |
3M Innovative Properties Company |
Adhesive compositions, articles incorporating same and methods of manufacture
|
US20040247654A1
(en)
*
|
2003-06-05 |
2004-12-09 |
3M Innovative Properties Company |
Hydrophilic adhesives for delivery of herbal medicines
|
US8524272B2
(en)
|
2003-08-15 |
2013-09-03 |
Mylan Technologies, Inc. |
Transdermal patch incorporating active agent migration barrier layer
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
JP5594925B2
(ja)
|
2004-01-30 |
2014-09-24 |
コリウム インターナショナル, インコーポレイテッド |
活性物質の送達のための急速に溶解するフィルム
|
US20050261654A1
(en)
*
|
2004-05-21 |
2005-11-24 |
Swanson Paul J |
Method and apparatus for warming accessories for diapers and the like
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
MX2007001512A
(es)
|
2004-08-05 |
2007-04-20 |
Corium Int Inc |
Composicion adhesiva.
|
JP2008519784A
(ja)
*
|
2004-11-12 |
2008-06-12 |
イデア アクチェンゲゼルシャフト |
皮膚状態の治療における拡張表面凝集体
|
US7999023B2
(en)
*
|
2004-12-03 |
2011-08-16 |
3M Innovative Properties Company |
Process for making pressure sensitive adhesive hydrogels
|
DE102005004924A1
(de)
*
|
2005-02-02 |
2006-08-03 |
Paul Hartmann Ag |
Wundauflage
|
EP1895995A2
(de)
*
|
2005-05-13 |
2008-03-12 |
Alza Corporation |
Mehrschichtige transdermale systeme zur galantamine abgabe
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
US10137135B2
(en)
|
2005-08-15 |
2018-11-27 |
Allergan Sales, Llc |
Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
|
US7955677B2
(en)
*
|
2005-12-07 |
2011-06-07 |
Mylan Technologies, Inc. |
Two-sided non-stick release film
|
CA2667678A1
(en)
|
2006-10-25 |
2008-07-24 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
CA2840407A1
(en)
*
|
2007-05-22 |
2008-12-18 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
CA2692884C
(en)
|
2007-07-10 |
2016-09-20 |
Agile Therapeutics, Inc. |
Dermal delivery device with in situ seal
|
WO2009009651A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Agile Therapeutics, Inc. |
Dermal delivery device with ultrasonic weld
|
US20090291127A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
WO2010021666A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Thomson Licensing |
Refined depth map
|
US20100080842A1
(en)
*
|
2008-09-30 |
2010-04-01 |
Jianye Wen |
Transdermal extended-delivery donepezil compositions and methods for using the same
|
EP2201941A1
(de)
*
|
2008-12-29 |
2010-06-30 |
UCB Pharma GmbH |
Pflaster-Herstellungstechnologie
|
US8784879B2
(en)
|
2009-01-14 |
2014-07-22 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
US20100178307A1
(en)
*
|
2010-01-13 |
2010-07-15 |
Jianye Wen |
Transdermal anti-dementia active agent formulations and methods for using the same
|
SG193434A1
(en)
|
2011-03-16 |
2013-10-30 |
Amgen Inc |
Potent and selective inhibitors of nav1.3 and nav1.7
|
WO2013053480A1
(de)
|
2011-10-11 |
2013-04-18 |
Secutech International Pte. Ltd. |
Zusammensetzung zur einbringung von nukleinsäuren in zellen
|
US9006462B2
(en)
|
2013-02-28 |
2015-04-14 |
Dermira, Inc. |
Glycopyrrolate salts
|
JP6114841B2
(ja)
|
2013-02-28 |
2017-04-12 |
ダーミラ, インク.Dermira, Inc. |
グリコピロレート塩
|
US8558008B2
(en)
|
2013-02-28 |
2013-10-15 |
Dermira, Inc. |
Crystalline glycopyrrolate tosylate
|
EP2970408B1
(de)
|
2013-03-12 |
2018-01-10 |
Amgen Inc. |
Hochwirksame und selektive inhibitoren von nav1.7
|
BR112016006883A2
(pt)
|
2013-09-30 |
2017-08-01 |
3M Innovative Properties Co |
composição de copolímero, adesivo sensível à pressão e método de preparo de uma composição de copolímero
|
US11607026B2
(en)
*
|
2014-05-30 |
2023-03-21 |
Johnson & Johnson Consumer Inc. |
Device for delivery of skin care composition
|
CN104208807B
(zh)
*
|
2014-08-14 |
2016-06-15 |
王丽 |
用于疤痕修复及美容的节约用药的医疗设备
|
CN105749417A
(zh)
*
|
2014-08-14 |
2016-07-13 |
王丽 |
一种用于疤痕修复的医疗设备
|
KR102419767B1
(ko)
|
2016-06-23 |
2022-07-12 |
코리움, 인크. |
친수성 및 소수성 도메인 및 치료제가 포함된 접착성 매트릭스
|
EP3490540A1
(de)
|
2016-07-27 |
2019-06-05 |
Corium International, Inc. |
Natriumbicarbonat in-situ
|
CA3032103A1
(en)
|
2016-07-27 |
2018-02-01 |
Corium International, Inc. |
Memantine transdermal delivery systems
|
US11318190B2
(en)
|
2017-05-05 |
2022-05-03 |
United States Government As Represented By The Department Of Veterans Affairs |
Methods and compositions for treating liver disease
|
CA3071007A1
(en)
*
|
2017-07-26 |
2019-01-31 |
Corium, Inc. |
Transdermal delivery system with a microporous membrane having solvent-filled pores
|
CA3086163A1
(en)
|
2017-12-20 |
2019-06-27 |
Corium, Inc. |
Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
|
US20220154041A1
(en)
|
2019-04-01 |
2022-05-19 |
3M Innovative Properties Company |
Process for making pressure sensitive adhesive hydrogels
|